Novel 1,3-dihydroisoindole derivatives of the formula (I), in which R
1
-R
3
have the meanings indicated in claim
1
, are HSP90 inhibitors and can be used for the preparation of a medicament for the treatment of diseases in which the inhibition, regulation and/or modulation of HSP90 plays a role.
新颖的式(I)的1,3-二氢异
吲哚衍
生物,其中R1-R3具有权利要求书中所指示的含义,是HSP90
抑制剂,可用于制备用于治疗HSP90起作用的疾病的药物。